Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 12/20 | 0.93 |
| ▸ | CES1 | P23141 | 7/20 | 0.93 |
| ▸ | MAPT | P10636 | 2/20 | 0.75 |
| ▸ | BLM | P54132 | 2/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.75 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.75 |
| ▸ | MGLL | Q99685 | 1/20 | 0.75 |
| ▸ | PLA2G4C | Q9UP65 | 1/20 | 0.75 |
| ▸ | CES2 | O00748 | 2/20 | 0.71 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | F7 | P08709 | 1/20 | 0.61 |
| ▸ | F3 | P13726 | 1/20 | 0.61 |
| ▸ | GMNN | O75496 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29038500 | 1.00 | FAAH (0.93) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL2849161 | 1.00 | FAAH (0.93) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL8059738 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL8049506 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL27204763 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL24938529 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL4085373 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL24938531 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL8066150 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 | |
| SCHEMBL24939095 | 0.96 | FAAH (1.00) | FAAHCES1MAPTBLMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9497963-B2 | Methods and compositions for control of gypsy moth, Lymantria dispar | SIMON FRASER UNIVERSITY (CA) | 2016-11-22 | — | — | US | disclosed |
| US-20130045178-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar | SIMON FRASER UNIVERSITY (CA) | 2013-02-21 | — | — | US | disclosed |
| US-20100297059-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR | SIMON FRASER UNIVERSITY (CA) | 2010-11-25 | — | — | US | disclosed |
| US-20100190865-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar | SIMON FRASER UNIVERSITY (CA) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045178-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTH, Lymantria dispar | L3MBTL3, L3MBTL4, L3MBTL1 | FAAH 2135/4885CES1 2222/4885MAPT 4810/4885 |
| US-20100190865-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, Lymanria dispar | L3MBTL3, L3MBTL4, L3MBTL1 | FAAH 2300/4885CES1 2094/4885MAPT 4813/4885 |
| US-20100297059-A1 | METHODS AND COMPOSITIONS FOR CONTROL OF GYPSY MOTHS, LYMANRIA DISPAR | L3MBTL3, L3MBTL4, L3MBTL1 | FAAH 2374/4885CES1 2135/4885MAPT 4820/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.